Walleye Capital’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
GJL
Walleye Capital's CLB Position: Q3 2026 in Review
Walleye Capital sold out of Core Laboratories (CLB) in Q3 2026, closing a stake of 20,687 shares — an estimated $241K sold.
Walleye Capital first reported a position in CLB in Q3 2024 and held it in 2 quarters. The position peaked at $241K in Q2 2026. 179 funds tracked by Wall St. Rank hold CLB as of Q3 2026.
- Walleye Capital reported no remaining Core Laboratories position as of Q3 2026 after selling out during the quarter.
- Walleye Capital sold 20,687 Core Laboratories shares in Q3 2026, an estimated $241K.
- Walleye Capital first reported a position in Core Laboratories in Q3 2024 and held it in 2 quarters.
- Walleye Capital's Core Laboratories position peaked at $241K in Q2 2026.
- 179 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.